Skip to main content
Top
Published in: Clinical Rheumatology 8/2011

01-08-2011 | Original Article

Association and frequency of HLA-A, B and HLA-DR genes in south Tunisian patients with spondyloarthritis (SpA)

Authors: Nadia Mahfoudh, Mariam Siala, Markus Rihl, Arwa Kammoun, Faten Frikha, Hela Fourati, Mohamed Younes, Radhouane Gdoura, Lilia Gaddour, Faiza Hakim, Zouheir Bahloul, Sofien Baklouti, Naceur Bargaoui, Sleheddine Sellami, Adnene Hammami, Hafedh Makni

Published in: Clinical Rheumatology | Issue 8/2011

Login to get access

Abstract

The aim of this study is to investigate the association of HLA-A, B and HLA-DR gene expression and to assess an association of additional HLA antigens besides HLA-B27 in south Tunisian patients with spondyloarthritis (SpA). Eighty-five patients diagnosed with ankylosing spondylitis (AS, n = 68) and reactive arthrithis (ReA, n = 17) were selected and compared with 100 healthy controls (HC). HLA class I antigens were typed serologically using microlymphocytotoxicity technique. HLA-DRB1* alleles were studied by polymerase chain reaction amplification with sequence-specific primers. The significance of differences between patients and controls was tested by chi-square analysis. We found significantly increased frequencies of HLA-A3 (30.6%; pC = 0.04; OR = 2.95), HLA-B27 (62.35%; pC = 4.10−17, OR = 53.55), and HLA-DRB1*15 (17.2%; pC = 0.026; RR = 2.58) alleles in SpA patients compared to HC. The most frequent and strongest association was observed for HLA-B27 in AS (pC = 6.6 × 10−16, OR = 52.23). When AS and ReA patients were analysed separately, HLA-DRB1*15 and HLA-A3 were increased only in AS (pC = 0.01, OR = 2.99 and pC = 0.03, OR = 3.14, respectively). In ReA patients, HLA-DRB1*04 (p = 0.033, pC = NS, OR = 2.89) was found to be the most common allele. By analysing the HLA-B27-negative subgroup, HLA-A3 and HLA-DRB1*15 expression was found to be dependent on the presence of HLA-B27. HLA-B27 expression was higher in male (45/53; 85%) as compared to female (8/53; 15%) patients (p = 0.03). Apart from HLA-B27, HLA-A3 and HLA-DRB1*15 are the MHC class I and II alleles found most frequent in Tunisian patients with AS, whereas HLA-DRB1*04 was found most frequent in ReA patients. HLA-B27 is more frequent in male than in female patients.
Literature
1.
go back to reference Lopez de Castro JA (2006) HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 15:27–33 Lopez de Castro JA (2006) HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol Lett 15:27–33
2.
go back to reference Reveille JD, Arnett FC (2005) Spondyloarthritis: update on pathogenesis and management. Am J Med 118:592–603PubMedCrossRef Reveille JD, Arnett FC (2005) Spondyloarthritis: update on pathogenesis and management. Am J Med 118:592–603PubMedCrossRef
3.
go back to reference Hannu T, Inman R, Granfors K, Leirisalo-Repo M (2006) Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol 20:419–433PubMedCrossRef Hannu T, Inman R, Granfors K, Leirisalo-Repo M (2006) Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol 20:419–433PubMedCrossRef
4.
go back to reference Toussirot E, Wendling D (2006) Immunogenetic of ankylosing spondylitis. Rev Méd Interne 27:762–771PubMedCrossRef Toussirot E, Wendling D (2006) Immunogenetic of ankylosing spondylitis. Rev Méd Interne 27:762–771PubMedCrossRef
5.
go back to reference Khan MA (1997) Prevalence of HLA B27 in world populations. In: Lopez-Larrea C (ed) HLA B27 in the development of spondyloarthropathies. Landes Springer, Austin, p 1e16 Khan MA (1997) Prevalence of HLA B27 in world populations. In: Lopez-Larrea C (ed) HLA B27 in the development of spondyloarthropathies. Landes Springer, Austin, p 1e16
6.
go back to reference Gonzalez-Roces S, Alvarez MW, Gonzalez S et al (1997) HLA B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123PubMedCrossRef Gonzalez-Roces S, Alvarez MW, Gonzalez S et al (1997) HLA B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123PubMedCrossRef
7.
go back to reference Tuokko J, Reijonen H, Ilonen J et al (1997) Increase of HLA-DRB1*0408 and –DQB1*0301 in HLA-B27 positive reactive arthritis. Ann Rheum Dis 56:37–40PubMedCrossRef Tuokko J, Reijonen H, Ilonen J et al (1997) Increase of HLA-DRB1*0408 and –DQB1*0301 in HLA-B27 positive reactive arthritis. Ann Rheum Dis 56:37–40PubMedCrossRef
8.
go back to reference Breban WTN, Miceli-Richard C, Zineviova E (2006) The genetics of spondylarthropathies. Joint Bone Spine 73:355–362PubMedCrossRef Breban WTN, Miceli-Richard C, Zineviova E (2006) The genetics of spondylarthropathies. Joint Bone Spine 73:355–362PubMedCrossRef
9.
go back to reference Brown MA, Kennedy GL, Darke C et al (1998) The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 41:460–465PubMedCrossRef Brown MA, Kennedy GL, Darke C et al (1998) The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 41:460–465PubMedCrossRef
10.
go back to reference Vargas-Alarcón, Londoño JD, Hernández-Pacheco G, Pacheco-Tena C, Castillo E, Cardiel MH, Granados J, Burgos-Vargas R (2002) Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 61:714–717PubMedCrossRef Vargas-Alarcón, Londoño JD, Hernández-Pacheco G, Pacheco-Tena C, Castillo E, Cardiel MH, Granados J, Burgos-Vargas R (2002) Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 61:714–717PubMedCrossRef
11.
go back to reference Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, Bettosini F, Mathieu A, Sorrentino R (2003) Two distinctive hla haplotypes harbor the b27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia. Arthritis Rheum 48:1385–1389PubMedCrossRef Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, Bettosini F, Mathieu A, Sorrentino R (2003) Two distinctive hla haplotypes harbor the b27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia. Arthritis Rheum 48:1385–1389PubMedCrossRef
12.
go back to reference Hajjej-Hajjej A, Kâabi H, Sellami MH et al (2006) The contribution of HLA class I and II alleles and haplotypes to the investigation of the evolutionary history of Tunisians. Tissue Antigens 68:153–162CrossRef Hajjej-Hajjej A, Kâabi H, Sellami MH et al (2006) The contribution of HLA class I and II alleles and haplotypes to the investigation of the evolutionary history of Tunisians. Tissue Antigens 68:153–162CrossRef
13.
go back to reference Ayed K, Ayed-Jendoubi S, Sfar I, Labonne MP, Gebuhrer L (2004) HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data. Tissue Antigens 64:520–532PubMedCrossRef Ayed K, Ayed-Jendoubi S, Sfar I, Labonne MP, Gebuhrer L (2004) HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data. Tissue Antigens 64:520–532PubMedCrossRef
14.
go back to reference Kchir MM, Hamdi W, Laadhar L et al (2010) HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case–control study). Rheumatol Int 30:933–939PubMedCrossRef Kchir MM, Hamdi W, Laadhar L et al (2010) HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case–control study). Rheumatol Int 30:933–939PubMedCrossRef
15.
go back to reference Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
16.
go back to reference Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef
17.
go back to reference Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327PubMedCrossRef Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327PubMedCrossRef
18.
go back to reference Terasaki PI, Mcclemmand JD (1964) Microdropletassay of human serum cytotoxins. Nature 204:998–1000PubMedCrossRef Terasaki PI, Mcclemmand JD (1964) Microdropletassay of human serum cytotoxins. Nature 204:998–1000PubMedCrossRef
19.
go back to reference Degos L (1985) La répartition anthropologique des gènes HLA et dynamique des populations. In: Dausset J, Pla M (eds) HLA, Complexe majeur d'histocompatibilité de l'homme. Médecine-Sciences, Flammarion, pp 101–119 Degos L (1985) La répartition anthropologique des gènes HLA et dynamique des populations. In: Dausset J, Pla M (eds) HLA, Complexe majeur d'histocompatibilité de l'homme. Médecine-Sciences, Flammarion, pp 101–119
20.
go back to reference Colombani J. (1993) Évolution du CPMH, des gènes et des allèles. La superfamille des immunoglobulines. Génétique des populations. In: HLA, fonctions immunitaires et applications médicales. J. Libbey: Eurotext Médecine sciences. p. 91–110 Colombani J. (1993) Évolution du CPMH, des gènes et des allèles. La superfamille des immunoglobulines. Génétique des populations. In: HLA, fonctions immunitaires et applications médicales. J. Libbey: Eurotext Médecine sciences. p. 91–110
21.
go back to reference Jaakkola E, Herzberg I, Laiho K, Barnardo MCN M, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA (2006) Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 65:775–780PubMedCrossRef Jaakkola E, Herzberg I, Laiho K, Barnardo MCN M, Pointon JJ, Kauppi M, Kaarela K, Tuomilehto-Wolf E, Tuomilehto J, Wordsworth BP, Brown MA (2006) Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis 65:775–780PubMedCrossRef
22.
go back to reference Tamouza R, Awada H, Marzais F, Teisserenc H, Poirier JC, Toubert A, Raffoux C, Charron D (1996) HLA B27 in the Lebanese population: subtype analysis and association with ankylosing spondylitis (SA). Hum Immunol 47:74–76CrossRef Tamouza R, Awada H, Marzais F, Teisserenc H, Poirier JC, Toubert A, Raffoux C, Charron D (1996) HLA B27 in the Lebanese population: subtype analysis and association with ankylosing spondylitis (SA). Hum Immunol 47:74–76CrossRef
23.
go back to reference Younsi R, Azrib S, Aitouazar M et al. (2007) Evaluation de l'incidence du gene HLAB-27 chez le patient atteint de spondylarthrite ankylosante au Maroc. 20 éme congrés de la sociéte francaise de rhumatologie (SFR) Younsi R, Azrib S, Aitouazar M et al. (2007) Evaluation de l'incidence du gene HLAB-27 chez le patient atteint de spondylarthrite ankylosante au Maroc. 20 éme congrés de la sociéte francaise de rhumatologie (SFR)
24.
go back to reference Vargas-Alarcon G, Garcia A, Bahena S, Melin-Aldana H, Andrade F, Ibafiez-de-Kasep G, Alcocer-Varela J, Alarcon-Segovia D, Granados J (1994) HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis 53:755–758PubMedCrossRef Vargas-Alarcon G, Garcia A, Bahena S, Melin-Aldana H, Andrade F, Ibafiez-de-Kasep G, Alcocer-Varela J, Alarcon-Segovia D, Granados J (1994) HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies. Ann Rheum Dis 53:755–758PubMedCrossRef
25.
go back to reference Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J (2009) The early disease stage in axial spondylarthritis: results from the German spondyloarthritis inception cohort. Arthritis Rheum 60:717–727PubMedCrossRef Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J (2009) The early disease stage in axial spondylarthritis: results from the German spondyloarthritis inception cohort. Arthritis Rheum 60:717–727PubMedCrossRef
Metadata
Title
Association and frequency of HLA-A, B and HLA-DR genes in south Tunisian patients with spondyloarthritis (SpA)
Authors
Nadia Mahfoudh
Mariam Siala
Markus Rihl
Arwa Kammoun
Faten Frikha
Hela Fourati
Mohamed Younes
Radhouane Gdoura
Lilia Gaddour
Faiza Hakim
Zouheir Bahloul
Sofien Baklouti
Naceur Bargaoui
Sleheddine Sellami
Adnene Hammami
Hafedh Makni
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1705-6

Other articles of this Issue 8/2011

Clinical Rheumatology 8/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.